Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2010, Vol. 4 Issue (4) : 436-442     DOI: 10.1007/s11684-010-0200-9
Research articles |
The first year follow-up after colorectal adenoma polypectomy is important: A multiple-center study in symptomatic hospital-based individuals in China
Qin-Yan GAO1,Hui-Min CHEN1,Jing-Yuan FANG1,Jian-Qiu SHENG2,Ping ZHENG3,Cheng-Gong YU4,Bo JIANG5,
1.Department of Gastroenterology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Digestive Disease, Shanghai 200001, China; 2.Department of Gastroenterology, PLA. The Military General Hospital of Beijing, Beijing 100700, China; 3.Shanghai 1st Hospital, Shanghai Jiao Tong University, Shanghai 200001, China; 4.Department of Gastroenterology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China; 5.Department of Gastroenterology, Nanfang Hospital, Nanfang University, Guangzhou 510515, China;
Download: PDF(132 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  The recurrence of colorectal adenoma (CRA) is high. Although there are guidelines for colonoscopy surveillance after polypectomy in other countries, little is known about its recurrence rate and recurrence peak, especially in China. The aim of the present research is to investigate how long after polypectomy follow-up should take and to analyze risk factors of recurrence. 1208 patients who received polypectomies from five clinical research centers in four regions of China (Shanghai, Guangzhou, Nanjing and Beijing) were included. They were divided into 4 groups: group A (follow-up≤1 year after polypectomy), group B (follow-up 2–3 years after polypectomy), group C (follow-up 4–5 years after polypectomy), and group D (follow-up>5 years after polypectomy). The sex, age, adenoma location, size, number, and pathological characteristics were compared. On the whole, the recurrence rate was 59.46% in group A, 61.09% in group B, 78.07% in group C, and 87.12% in group D, which indicated an increased tendency with a prolonged follow-up duration. There was a significant difference between group A and C or D, and between group B and C or D (P<0.01), but there was no statistical difference between group A and B. Additionally, the recurrent patients in the first year had a recurrence rate of 97.33% in the first three years (59.46/61.09), which means that the peak of recurrence was almost entirely concentrated in the first year. The recurrence rate was higher in males and the elder. The risk factors included multiple numbers, villous feature, high-grade dysplasia of medium or smaller size and location in the distal colon. In conclusion, the peak of recurrence was almost totally concentrated in the first year; meanwhile, the first year follow-up is of critical importance in China. It may not be necessary to do the follow-up examination during the second and third years, but after three years, another colonoscopy should be undertaken.
Keywords colorectal adenoma      polypectomy      follow-up      recurrence      risk factor      
Issue Date: 05 December 2010
URL:  
http://academic.hep.com.cn/fmd/EN/10.1007/s11684-010-0200-9     OR     http://academic.hep.com.cn/fmd/EN/Y2010/V4/I4/436
Lieberman D A, Weiss D G, Bond J H, Ahnen D J, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults forcolorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med, 2000, 343(3): 162–168
PMID: 10900274
Cotton S, Sharp L, Little J. The adenoma-carcinoma sequence and prospectsfor the prevention of colorectal neoplasia. Crit Rev Oncog, 1996, 7(5―6): 293–342
PMID: 9467664
Winawer S J, Zauber A G, Ho M N, O'Brien M J, Gottlieb L S, Sternberg S S, Waye J D, Schapiro M, Bond J H, Panish J F, Ackroyd F, Shike M, Kurtz R C, Hornsby-Lewis L, Gerdes H, Stewart E T. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med, 1993, 329(27): 1977–1981
PMID: 8247072
Strul H, Kariv R, Leshno M, Halak A, Jakubowicz M, Santo M, Umansky M, Shirin H, Degani Y, Revivo M, Halpern Z, Arber N. The prevalence rate and anatomic location of colorectal adenoma andcancer detected by colonoscopy in average-risk individuals aged 40―80years. Am J Gastroenterol, 2006, 101(2): 255–262
PMID: 16454827
Selby J V, Friedman G D, Quesenberry C P Jr, Weiss N S. A case-control study of screening sigmoidoscopyand mortality from colorectal cancer. N Engl J Med, 1992, 326(10): 653–657
PMID: 1736103
Newcomb P A, Norfleet R G, Storer B E. Surawicz T S, Marcus P M. Screening sigmoidscopy and colorectal cancer mortality. J Natl Cancer Inst, 1992, 84: 1572–1575
PMID: 1404450
Martínez M E, Baron J A, Lieberman D A, Schatzkin A, Lanza E, Winawer S J, Zauber A G, Jiang R, Ahnen D J, Bond J H, Church T R, Robertson D J, Smith-Warner S A, Jacobs E T, Alberts D S, Greenberg E R. A pooled analysis of advancedcolorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology, 2009, 136(3): 832–841
PMID: 19171141
Winawer S J, Zauber A G, O'Brien M J, Ho M N, Gottlieb L S, Sternberg S S, Waye J D, Bond J H, Schapiro M, Stewart E T, Panish J F, Ackroyd F, Kurtz R C, Shike M. Randomized comparison of surveillanceintervals after colonoscopic removal of newly diagnosed adenomatouspolyps. N Engl J Med, 1993, 328(13): 901–906
PMID: 8446136
J?rgensen O D, Kronborg O, Fenger C. A randomized surveillancestudy of patients with pedunculated and small sessile tubular andtubulovillous adenomas. The Funen Adenoma Follow-up Study. Scand J Gastroenterol, 1995, 30(7): 686–692
PMID: 7481533
Winawer S J, Zauber A G, Fletcher R H, Stillman J S, O'Brien M J, Levin B, Smith R A, Lieberman D A, Burt R W, Levin T R, Bond J H, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex D K. Guidelines for colonoscopy surveillance after polypectomy: a consensus updateby the US Multi-Society Task Force on Colorectal Cancer and the AmericanCancer Society. Gastroenterology, 2006, 130(6): 1872–1885
PMID: 16697750
Sung J J, Lau J Y, Young G P, Sano Y, Chiu H M, Byeon J S, Yeoh K G, Goh K L, Sollano J, Rerknimitr R, Matsuda T, Wu K C, Ng S, Leung S Y, Makharia G, Chong V H, Ho K Y, Brooks D, Lieberman D A, Chan F K. Asia Pacific consensusrecommendations for colorectal cancer screening. Gut, 2008, 57(8): 1166–1176
PMID: 18628378
Rundle A G, Lebwohl B, Vogel R, Levine S, Neugut A I. Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years. Gastroenterology, 2008, 134(5): 1311–1315
PMID: 18471508
Phillips K A, Liang S Y, Ladabaum U, Haas J, Kerlikowske K, Lieberman D, Hiatt R, Nagamine M, Van Bebber S L. Trends in colonoscopy for colorectal cancer screening. Med Care, 2007, 45(2): 160–167
PMID: 17224779
The Lancet Oncology. Prevention at a cost. Lancet Oncol, 2004, 5(10): 581
PMID: 15465457
Winawer S J, Zauber A G, Fletcher R H, Stillman J S, O'Brien M J, Levin B, Smith R A, Lieberman D A, Burt R W, Levin T R, Bond J H, Brooks D, Byers T, Hyman N, Kirk L, Thorson A, Simmang C, Johnson D, Rex D K. Guidelines for colonoscopy surveillance after polypectomy: a consensus updateby the US Multi-Society Task Force on Colorectal Cancer and the AmericanCancer Society. Gastroenterology, 2006, 130(6): 1872–1885
PMID: 16697750
Noshirwani K C, van Stolk R U, Rybicki L A, Beck G J. Adenoma size and number are predictive of adenoma recurrence:implications for surveillance colonoscopy. Gastrointest Endosc, 2000, 51(4 Pt 1): 433–437
PMID: 10744815
Nusko G, Mansmann U, Kirchner T, Hahn E G. Risk related surveillance following colorectal polypectomy. Gut, 2002, 51(3): 424–428
PMID: 12171968
van Stolk R U, Beck G J, Baron J A, Haile R, Summers R. Adenoma characteristics atfirst colonoscopy as predictors of adenoma recurrence and characteristicsat follow-up. Gastroenterology, 1998, 115(1): 13–18
PMID: 9649453
Martínez M E, Sampliner R, Marshall J R, Bhattacharyya A K, Reid M E, Alberts D S. Adenoma characteristics asrisk factors for recurrence of advanced adenomas. Gastroenterology, 2001, 120(5): 1077–1083
PMID: 11266371
Lieberman D A, Weiss D G, Harford W V, Ahnen D J, Provenzale D, Sontag S J, Schnell T G, Chejfec G, Campbell D R, Kidao J, Bond J H, Nelson D B, Triadafilopoulos G, Ramirez F C, Collins J F, Johnston T K, McQuaid K R, Garewal H, Sampliner R E, Esquivel R, Robertson D. Five-year colon surveillance after screening colonoscopy. Gastroenterology, 2007, 133(4): 1077–1085
PMID: 17698067
[1] Alexandra Urman,H. Dean Hosgood. Curbing the burden of lung cancer[J]. Front. Med., 2016, 10(2): 228-232.
[2] Zhiming Zhu, Peijian Wang, Shuangtao Ma. Metabolic hypertension: concept and practice[J]. Front Med, 2013, 7(2): 201-206.
[3] Jin Gao, Ben Panizza, Newell W. Johnson, Scott Coman, Alan R. Clough. Basic consideration of research strategies for head and neck cancer[J]. Front Med, 2012, 6(4): 339-353.
[4] Marie-Germaine Bousser. Stroke prevention: an update[J]. Front Med, 2012, 6(1): 22-34.
[5] Jing CHEN MD, Guang-Yuan HU MD, Guo-Qing HU MD, Hua WU PhD, . Technetium-99m-sestamibi SPECT for the diagnosis and follow-up of nasopharyngeal carcinoma[J]. Front. Med., 2010, 4(1): 96-100.
[6] Chen WANG PhD, MD, Zhen-Guo ZHAI PhD, MD, Ying H. SHEN PhD, MD, Lan ZHAO PhD, MD, . Clinical and genetic risk factors for venous thromboembolism in Chinese population[J]. Front. Med., 2010, 4(1): 29-35.
[7] Jun-Jie XIAO MD, Yi-Han CHEN MD, PhD, . Prevalence of cardiovascular diseases in China[J]. Front. Med., 2010, 4(1): 16-20.
[8] Qiong DAI MD, Bei LIU MD, Yukai DU MM, . Meta-analysis of the risk factors of breast cancer concerning reproductive factors and oral contraceptive use[J]. Front. Med., 2009, 3(4): 452-458.
[9] PAN Jiangang, ZHOU Xing, CHEN Zhiguang, HAN Ruifa. A meta-analysis of randomized trials of maintenance bacillus Calmette-Guerin instillation efficacy against recurrence of T1G3 bladder tumor[J]. Front. Med., 2008, 2(3): 259-263.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed